Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corp    CVS

Delayed Quote. Delayed  - 09/23 10:01:04 pm
90.6 USD   +0.03%
09/25 PHARMACY SHUTDO : Independent businesses being swallowed up by falli..
09/22 DAILY DIVIDEND : Lmt, idcc, safm, cvs, len
09/22 CVS HEALTH CORP : Announces Quarterly Dividend
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

CVS Caremark 4th-Quarter Profit Rose 2.6% Amid Continued Sales Growth

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/06/2013 | 01:52pm CEST
   By Tess Stynes 
 

CVS Caremark Corp.'s (>> CVS Caremark Corporation) fourth-quarter earnings rose 2.6% as the company reported revenue growth in its pharmacy-services and retail drugstore operations.

For the year, the company raised its forecast for per-share adjusted earnings from continuing operations by two cents and now expects $3.86 to $4.

CVS's retail pharmacy business gained customers last year in the wake of a contract dispute between rival Walgreen Co.'s (>> Walgreen Company) and pharmacy-benefits manager Express Scripts Holding Co. (>> Express Scripts Holding Co) that has since been resolved.

A wave of major generic drugs introductions is having a mixed effect on the industry. Though the copycat drugs carry higher margins than branded products, they command lower prices, hurting sales revenue.

CVS Caremark reported a profit of $1.13 billion, or 90 cents a share, up from $1.1 billion, or 81 cents a share, a year earlier. Excluding debt-extinguishment losses, acquisition-related charges and other items, adjusted earnings from continuing operations were $1.14. Revenue increased 11% to $31.39 billion.

Analysts polled by Thomson Reuters most recently projected earnings of $1.10 on revenue of $31.13 billion.

Revenue in the larger pharmacy-services business climbed 17% to $18.6 billion, reflecting new client starts, higher prices and growth of its Medicare Part D program. Pharmacy network claims processed rose 6.5%.

On the retail side, revenue increased 5.1% to $16.3 billion. Same-store sales were up 4% from a year earlier, as pharmacy same-store sales also improved by 4%. Same-store sales in the front end of the store grew 3.9%.

Shares closed Tuesday at $51.72 and were inactive premarket.

Write to Tess Stynes at tess.stynes@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORP
09/25 PHARMACY SHUTDOWNS : Independent businesses being swallowed up by falling reimbu..
09/22 DAILY DIVIDEND REPORT : Lmt, idcc, safm, cvs, len
09/22 CVS HEALTH CORPORATION : Announces Quarterly Dividend
09/22 CVS HEALTH : The First Tobacco-Free Generation Is Within Reach
09/22 CVS HEALTH : to offer curbside pickup in Chicago area
09/19 CVS HEALTH : Expands Youth Drug Abuse Prevention Efforts for the 2016-2017 Schoo..
09/15 CVS HEALTH : Increasing Access to Health Care with Annual Project Health Campaig..
09/15 CVS HEALTH : 's ScriptSync® Service Marks One Year Anniversary
09/15 CVS HEALTH : EDITORIAL CVS settlement is positive step in addiction fight
09/14 CVS HEALTH : Bringing Health Screenings to Underserved Communities
More news
Sector news : Drug Retailers - NEC
09/23DJRITE AID : Business Watch -- WSJ
09/22DJRITE AID : Same-Store Sales Fall Amid Generics Pressure
09/15 MCKESSON : German antitrust watchdog raids drugs distributors
09/14DJGoogle Acquisition Apigee's Revenue Climbs
09/14DJGoogle Acquisition Apigee's Revenue Climbs
More sector news : Drug Retailers - NEC
News from SeekingAlpha
09/25 PORTFOLIO PURCHASES : Adding 3 Companies With More Than 15% Upside To Our Divide..
09/23 Examining The Core Value Of REITs
09/22 Where Did All That EpiPen Money Go?
09/22 CVS Health declares $0.425 dividend
09/22 Amazon Threatens The Photo Printing Services Of Shutterfly, CVS, Walgreens, W..
Advertisement
Financials ($)
Sales 2016 179 864 M
EBIT 2016 10 786 M
Net income 2016 5 715 M
Debt 2016 24 998 M
Yield 2016 1,80%
P/E ratio 2016 17,50
P/E ratio 2017 14,55
EV / Sales 2016 0,68x
EV / Sales 2017 0,62x
Capitalization 96 599 M
More Financials
Chart CVS HEALTH CORP
Duration : Period :
CVS Health Corp Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Full-screen chart
Technical analysis trends CVS HEALTH CORP
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 111 $
Spread / Average Target 23%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Stephen J. Gold Chief Information Officer & Executive Vice Preside
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORP-7.33%96 599
WALGREENS BOOTS ALLIAN..-3.65%88 804
EXPRESS SCRIPTS HOLDIN..-18.38%44 960
MCKESSON CORPORATION-15.29%37 710
CARDINAL HEALTH INC-13.01%24 848
AMERISOURCEBERGEN CORP..-19.65%19 823
More Results